Advertisement

Nexia Biotechnologies Inc Company Profile

06:52 EDT 22nd May 2013 | BioPortfolio

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.

Location

P.O. BOX 187Branch Jean-Talon
Montreal
Quebec
H1S 2Z2
Canada

Contact

Phone: 514.586.3942
Fax: 514.371.7880
Email: investors@nexiabiotech.com


News Articles [ 125 Associated News Articles listed on BioPortfolio]

Stellar Biotechnologies develops aquaculture system for KLH manufacturing

Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing.

Stellar Biotechnologies to Present at Nobel Financial Capital Markets Ninth Annual Equity Conference January 23, 2013

PORT HUENEME, CA -- (Marketwire) -- 01/17/13 -- Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of GMP-grad...

Stellar Biotechnologies Exceeds Aquaculture Capacity Goals / Facility Expansion and Cultivation Innovations Ensure Supply Leadership

PORT HUENEME, CA -- (Marketwire) -- 02/19/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan ...

Wilex, Nuclea Biotechnologies form partnership

Pittsfield, Mass-based biomarker pioneer Nuclea Biotechnologies has formed a new long-term partnership with biopharmaceutical company Wilex, which could lead to more effective treatment management for...

BMS pharma deals for oncology biomarkers in collaborative R&D with Adaptive biotechnologies

Bristol-Myers Squibb has entered into a collaborative R&D pharma deals agreement with Adaptive biotechnologies  for the discovery of immunological biomarkers in oncology. Under the pharma deals c...

USPTO grants patent to Lifeline Biotechnologies cancer analyzing device

The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detec...

Nuclea Biotechnologies, Inc.: Series B $3.4M

Nuclea Biotechnologies (Pittsfield, MA) a commercial-stage diagnostic company focused on in vitro companion diagnostic assays based on gene and protein expression profiles and biomarkers associated wi...

Fujifilm Diosynth Biotechnologies Expands Mammalian Cell Culture cGMP Capabilities

Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in mammalian cell line de...

Drugs and Medications [0 Results]

None

PubMed Articles [ 44 Associated PubMed Articles listed on BioPortfolio]

High Throughput Biotechnology in Traditional Fermented Food Industry.

Traditional fermented food is not only the staple food for most of developing countries but also the key healthy food for developed countries. As the healthy function of these foods are gradually disc...

Development and application of biotechnologies in the metal mining industry.

Metal mining faces a number of significant economic and environmental challenges in the twenty-first century for which established and emerging biotechnologies may, at least in part, provide the answe...

A Comparative Pilot Study of Two Dental Implant Metals in a Pig Model.

PURPOSE:: Successful implant treatment is based on implant stability, absence periimplant inflammation, and a functional interface between implant and bone tissue (direct bone-implant contact). The ai...

Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma.

Global food security and the governance of modern biotechnologies.

Clinical Trials [0 Results]

None

Companies [ 92 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and...

Nexia Holdings, Inc.

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

Epeius Biotechnologies Corp.

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its leading oncology pro...

More Information about "Nexia Biotechnologies Inc" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement